Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura

NCT04056507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-08-14

No results posted yet for this study

Summary

The aim of this study is to determine histological immunological parameters, sought on splenectomy pieces that may explain the failure or success of splenectomy in patients with ITP who had a splenectomy to treat their ITP(Immune thrombocytopenic purpura).

Conditions

  • Immune Thrombocytopenic Purpura
  • Splenectomy; Status

Interventions

PROCEDURE

Immunolabeling

Immunolabeling of abnormalities observed by the cell study in flow cytometry.

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Jean-François VIALLARD, Pr · University Hospital, Bordeaux

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-12
Primary Completion
2015-09-30
Completion
2015-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04056507 on ClinicalTrials.gov